MaxCyte

MaxCyte® is a leading cell-engineering company advancing the discovery, development, and commercialization of next-generation cell therapies. The company's Flow Electroporation® technology and SeQure DX™ gene editing risk assessment services provide precise, efficient, and scalable solutions for cell engineering. Supported by comprehensive scientific, technical, and regulatory expertise, MaxCyte’s ExPERT™ platform enables researchers to engineer a wide range of cell types and payloads, accelerating the development of safe and effective treatments. With more than 25 years of experience in cell engineering, MaxCyte continues to shape the future of medicine.

Content by MaxCyte

Graphic showing a DNA strand and red blood cells

Moving Gene Editing Advances Into the Clinic

The Scientist StaffandMaxCyte | | 4 min read

Page 1 of 1 - 1 Total Items

Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.

November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

In our next roundtable webinar, learn how scientists leverage spatial biology to map tissues, uncover cellular interactions, and advance disease research.

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Discover how scientists use the latest gene editing tools to advance health research.

Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease diagnostic journey and enable earlier intervention through its accessibility and high diagnostic performance.

Products

Product News

Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize

Findings link genetic variation, through circuit assembly, to animal behavior, paving the way to explore how developmental changes influence brain function

EVIDENT's New FLUOVIEW FV5000 Redefines the Boundaries of Confocal and Multiphoton Imaging

New precision imaging system delivers exceptional clarity and speed, absolute quantitation, and a simplified end-to-end user experience

EVIDENT Launches Sixth Annual Image of the Year Contest

The contest recognizes the best in scientific imaging worldwide - it’s a celebration of art, science, and technical mastery.

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies